Jennifer Champoux, Chief Operating Officer of Monte Rosa Therapeutics ($GLUE), sold shares once on the open market in the last 365 days for a total of nearly $40,000. Her most recent sale occurred on January 5, 2026. These sales rank her 10,612th among 11,678 individual insiders, far below the average sale amount of 8.6 million and 6.4 transactions per insider. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Monte Rosa Therapeutics, Inc. | $GLUE | Champoux Jennifer | Chief Operating Officer | A | Common Stock | 35000 | $0.00 | 65,000.0000 | 82,942,723 | 116.67% | 0.04% |
| Jan. 5, 2026 | Monte Rosa Therapeutics, Inc. | $GLUE | Champoux Jennifer | Chief Operating Officer | S | Common Stock | 2629 | $15.17 | 62,371.0000 | 82,942,723 | 4.04% | 0.00% |
| Jan. 2, 2026 | Monte Rosa Therapeutics, Inc. | $GLUE | Champoux Jennifer | Chief Operating Officer | A | Stock Option (Right to Buy) | 158000 | $0.00 | 158,000.0000 | 82,942,723 | 9999.99% | 0.19% |
| Jan. 2, 2025 | Monte Rosa Therapeutics, Inc. | $GLUE | Champoux Jennifer | Chief Operating Officer | A | Common Stock | 30000 | $0.00 | 30,000.0000 | 73,910,026 | 9999.99% | 0.04% |
| Jan. 2, 2025 | Monte Rosa Therapeutics, Inc. | $GLUE | Champoux Jennifer | Chief Operating Officer | A | Stock Option (Right to Buy) | 135000 | $0.00 | 135,000.0000 | 73,910,026 | 9999.99% | 0.18% |
| June 3, 2024 | Monte Rosa Therapeutics, Inc. | $GLUE | Champoux Jennifer | Chief Operating Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 51,396,961 | 9999.99% | 0.08% |